LncRNA FGD5-AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR-223 and regulating the expression of ECT2 and FAT1.

He, Chen-Kun; Li, Zeng-Bo; Yi, Da; Zhu, Xiang-Ya; Liu, Rong-Rong; Zhang, Dong-Xin; Cao, Qian; Chen, Yi-Ping

He, Chen-Kun; Li, Zeng-Bo; Yi, Da; Zhu, Xiang-Ya; Liu, Rong-Rong; Zhang, Dong-Xin; Cao, Qian; Chen, Yi-Ping.

Afiliação

He CK; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Li ZB; Department of Emergency, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Yi D; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Zhu XY; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Liu RR; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Zhang DX; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Cao Q; Department of Endocrine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Chen YP; Medical Laboratory, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.

Hepatol Res ; 52(7): 614-629, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35366388

Palavras-chave

ECT2; FDG5-AS1; hepatocellular carcinoma; miR-223; proliferation; stemness

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google